10.11.2017 Views

Infectious Diseases Diagnostics Market

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

RESEARCH REPORT<br />

NOVEMBER 2017<br />

INFECTIOUS DISEASES DIAGNOSTICS MARKET<br />

SEGMENTED BY PRODUCT, APPLICATION, TECHNOLOGY, END-<br />

USER AND REGION-INDUSTRY ANALYSIS, SIZE, SHARE, GROWTH,<br />

TRENDS AND FORECASTS 2016-2021


<strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> Size is anticipated to grow at a 7.90% CAGR from<br />

2016 to 2021 and it is estimated that the global market was valued at USD 14.45 billion in<br />

2016 and is relied upon to achieve USD 21.13 billion by 2021. <strong>Infectious</strong> disease diagnostics<br />

involves various methods to check for the presence of foreign antigen/organism with the<br />

help of numerous diagnostic tools. <strong>Infectious</strong> disease conditions are highly widespread in<br />

under developed regions owing to the lack of awareness for personal hygiene, minimal<br />

health care expenditures, and absence of efficient physician services. Rising cases of<br />

infectious diseases in developed economies is further expected to boost the market growth.<br />

This has lead vitro diagnostic device manufacturers to invest into emerging economies.<br />

These companies are taking efforts to develop and commercialize cost effective tools for the<br />

infectious disease diagnosis.<br />

Disease diagnostics are used for confirmation of a disease in form of a quick, precise test<br />

result. Being time consuming, disease diagnostics are on a rise. The infectious disease<br />

epidemics are spreading worldwide, thereby leading to an increase in demand of diagnostic<br />

tests. In addition, the incidences of malaria, flu, AIDS, and other diseases are also on a rise,<br />

creating a robust demand for infectious disease diagnostics. With a majority of physicians<br />

adopting the evidence-based treatment method, infectious disease diagnostic kits are more<br />

likely to gain traction over the forecast period. Several government-funded programs all<br />

over the globe are increasingly providing free screening and tests in order to increase<br />

awareness, accurately diagnose diseases, and minimize the chances of infection. Such<br />

initiatives are anticipated to boost the market growth in the next few years. However,<br />

diagnostic kits are expensive and manufacturers still have a poor distribution channel for<br />

operating across emerging economies. These two factors are projected to be the key<br />

challenges to rapid revenue growth of the global infectious diseases diagnostics market.<br />

<strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> Segmentation by Product, Application, Technology<br />

and End User. On the basis of Product, it is segmented into Instruments, Reagents, Services,<br />

and Software. Consumables accounted for the largest share. On the basis of Application, it is<br />

segmented into Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis<br />

(TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus<br />

(HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola,<br />

Typhoid, Malaria, and Dengue) included. Hospital-acquired MRSA infections and human<br />

papillomavirus (HPV) are expected to be the fastest-growing market segments in the<br />

forecast period. On the basis of technology, it is segmented into PCR, INAAT, DNA<br />

Sequencing and Hybridization. Traditional methods are categorized into immunodiagnostics,<br />

microscopy, and biochemical characterization. Microarrays and INAAT are projected to<br />

witness the highest growth during the forecast period. This noteworthy growth can be<br />

accredited to the specificity and an increase in the efficiency of these tests. On the basis of<br />

End User, it is segmented into Hospital and Laboratories. Hospital laboratories and<br />

reference labs held the largest share in this market segment.<br />

<strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> geographical segmentation by North America,<br />

Europe, Asia-Pacific and Middle East and Africa. North America held the largest share of the


IDD market, followed by Europe. Both regions are projected to witness single-digit growth<br />

rates during the coming years. Be that as it may, Asia-Pacific is projected to register the<br />

highest growth rate in the coming years, due to the high pervasiveness of infectious<br />

diseases, and huge investment opportunities due to a growth in healthcare expenditure.<br />

<strong>Market</strong> Segmentation:<br />

1 Product<br />

1.1 Introduction<br />

1.2 Instruments & Analyzers<br />

1.3 Consumables<br />

1.3.1 Assays and Reagents<br />

1.4 Services & Softwares<br />

1.5 Y-o-Y Growth Analysis, By Product<br />

1.6 <strong>Market</strong> Attractiveness Analysis, By Product<br />

1.7 <strong>Market</strong> Share Analysis, By Product<br />

2 Techniques<br />

2.1 Introduction<br />

2.2 Traditional Diagnostic Techniques<br />

2.2.1 Immunodiagnostics<br />

2.2.2 Microscopy<br />

2.2.3 Biochemical Characterization<br />

2.3 Molecular <strong>Diagnostics</strong><br />

2.3.1 PCR<br />

2.3.2 INAAT<br />

2.3.2 Hybridization<br />

2.3.3 DNA Sequencing & NGS<br />

2.3.4 Microarray<br />

2.3.5 Others<br />

2.4 Y-o-Y Growth Analysis, By Technique<br />

2.5 <strong>Market</strong> Attractiveness Analysis, By Technique<br />

2.6 <strong>Market</strong> Share Analysis, By Technique


3 Applications<br />

3.1 Introduction<br />

3.2 Hepatitis B<br />

3.3 Hepatitis C<br />

3.4 Human Immunodeficiency Virus (HIV)<br />

3.5 Tuberculosis (TB)<br />

3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)<br />

3.7 Human papillomavirus (HPV)<br />

3.8 Methicillin-resistant Staphylococcus aureus (MRSA)<br />

3.9 Others<br />

3.10 Y-o-Y Growth Analysis, By Application<br />

3.11 <strong>Market</strong> Attractiveness Analysis, By Application<br />

3.12 <strong>Market</strong> Share Analysis, By Application<br />

4 End User<br />

4.1 Introduction<br />

4.2 Hospitals Laboratories<br />

4.3 Physician office Labs<br />

4.4 Academics<br />

4.5 Others<br />

The major <strong>Infectious</strong> <strong>Diseases</strong> <strong>Diagnostics</strong> <strong>Market</strong> leaders are Abbott Laboratories,<br />

bioMérieux SA, Hologic, Inc., Danaher Corporation, SBecton, Dickinson and Company,<br />

Cepheid, Inc., Thermo Fisher Scientific Inc., Roche <strong>Diagnostics</strong>, Alere Inc., DiaSorin S.p.A.,<br />

Quidel Corporation, and Bio-Rad Laboratories, Inc.<br />

TABLE OF CONTENTS<br />

1. Introduction<br />

1.1 <strong>Market</strong> Definition<br />

1.2 Study Deliverables


1.3 Base Currency, Base Year and Forecast Periods<br />

1.4 General Study Assumptions<br />

2. Research Methodology<br />

2.1 Introduction<br />

2.2 Research Phases<br />

2.2.1 Secondary Research<br />

2.2.2 Primary Research<br />

2.2.3 Econometric Modelling<br />

2.2.4 Expert Validation<br />

View Report at http://www.marketdataforecast.com/market-reports/infectious-diseasesdiagnostics-market-4607/<br />

2.3 Analysis Design<br />

2.4 Study Timeline<br />

3. Overview<br />

3.1 Executive Summary<br />

3.2 Key Inferences<br />

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />

4.1 <strong>Market</strong> Drivers<br />

4.2 <strong>Market</strong> Restraints<br />

4.3 Key Challenges<br />

4.4 Current Opportunities in the <strong>Market</strong>


Get free sample report at http://www.marketdataforecast.com/market-reports/infectiousdiseases-diagnostics-market-4607/request-sample<br />

5. <strong>Market</strong> Segmentation<br />

5.1 Product<br />

5.1.1 Introduction<br />

5.1.2 Instruments & Analyzers<br />

5.1.3 Consumables<br />

5.1.3.1 Assays and Reagents<br />

5.1.4 Services & Softwares<br />

5.1.5 Y-o-Y Growth Analysis, By Product<br />

5.1.6 <strong>Market</strong> Attractiveness Analysis, By Product<br />

5.1.7 <strong>Market</strong> Share Analysis, By Product<br />

5.2 Technique<br />

5.2.1 Introduction<br />

5.2.2 Traditional Diagnostic Techniques<br />

5.2.2.1 Immunodiagnostics<br />

5.2.2.2 Microscopy<br />

5.2.2.3 Biochemical Characterization<br />

5.2.3 Molecular <strong>Diagnostics</strong><br />

5.2.3.1 PCR<br />

5.2.3.2 INAAT<br />

5.2.3.2 Hybridization<br />

5.2.3.3 DNA Sequencing & NGS<br />

5.2.3.4 Microarray<br />

5.2.3.5 Others<br />

5.2.4 Y-o-Y Growth Analysis, By Technique<br />

5.2.5 <strong>Market</strong> Attractiveness Analysis, By Technique<br />

5.2.6 <strong>Market</strong> Share Analysis, By Technique


Request Customization at http://www.marketdataforecast.com/marketreports/infectious-diseases-diagnostics-market-4607/customize-report<br />

5.3 Application<br />

5.3.1 Introduction<br />

5.3.2 Hepatitis B<br />

5.3.3 Hepatitis C<br />

5.3.4 Human Immunodeficiency Virus (HIV)<br />

5.3.5 Tuberculosis (TB)<br />

5.3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)<br />

5.3.7 Human papillomavirus (HPV)<br />

5.3.8 Methicillin-resistant Staphylococcus aureus (MRSA)<br />

5.3.9 Others<br />

5.3.10 Y-o-Y Growth Analysis, By Application<br />

5.3.11 <strong>Market</strong> Attractiveness Analysis, By Application<br />

5.3.12 <strong>Market</strong> Share Analysis, By Application<br />

5.4 End User<br />

5.4.1 Introduction<br />

5.4.2 Hospitals Laboratories<br />

5.4.3 Physician office Labs<br />

5.4.4 Academics<br />

5.4.5 Others<br />

5.4.6 Y-o-Y Growth Analysis, By End User<br />

5.4.7 <strong>Market</strong> Attractiveness Analysis, By End User<br />

5.4.8 <strong>Market</strong> Share Analysis, By End User<br />

Enquire before buying at http://www.marketdataforecast.com/market-reports/infectiousdiseases-diagnostics-market-4607/inquire<br />

6. Geographical Analysis


6.1 North America<br />

6.2 Europe<br />

6.1.1 Introduction<br />

6.1.2 United States<br />

6.1.3 Canada<br />

6.2.1 Introduction<br />

6.2.2 U.K<br />

6.2.3 Spain<br />

6.2.4 Germany<br />

6.2.5 Italy<br />

6.2.6 France<br />

Buy this report at http://www.marketdataforecast.com/cart/buy-now/infectious-diseasesdiagnostics-market-4607<br />

6.3 Asia-Pacific<br />

6.3.1 Introduction<br />

6.3.2 China<br />

6.3.3 India<br />

6.3.4 Japan<br />

6.4 Latin America<br />

6.4.1 Introduction<br />

6.4.2 Brazil<br />

6.4.3 Argentina


6.4.4 Mexico<br />

6.5 Middle East & Africa<br />

6.5.1 Introduction<br />

6.5.2 Middle-East<br />

6.5.3 Africa<br />

7. Strategic Analysis<br />

7.1 PESTLE analysis<br />

7.1.1 Political<br />

7.1.2 Economic<br />

7.1.3 Social<br />

7.1.4 Technological<br />

7.1.5 Legal<br />

7.1.6 Environmental<br />

7.2 Porter’s Five analysis<br />

7.2.1 Bargaining Power of Suppliers<br />

7.2.2 Bargaining Power of Consumers<br />

7.2.3 Threat of New Entrants<br />

7.2.4 Threat of Substitute Products and Services<br />

7.2.5 Competitive Rivalry within the Industry<br />

8. <strong>Market</strong> Leaders' Analysis<br />

8.1 Abbott Laboratories<br />

8.1.1 Overview


8.1.2 Product Analysis<br />

8.1.3 Financial analysis<br />

8.1.4 Recent Developments<br />

8.1.5 SWOT analysis<br />

8.1.6 Analyst View<br />

8.2 bioMérieux SA<br />

8.3 Hologic Inc.<br />

8.4 Danaher Corporation<br />

8.5 Sbecton<br />

8.6 Dickinson and Company<br />

8.7 Cepheid Inc.<br />

8.8 Thermo Fisher Scientific Inc.<br />

8.9 Roche <strong>Diagnostics</strong><br />

8.10 Alere Inc.<br />

9. Competitive Landscape<br />

9.1 <strong>Market</strong> share analysis<br />

9.2 Merger and Acquisition Analysis<br />

9.3 Agreements, collaborations and Joint Ventures<br />

9.4 New Product Launches<br />

10. <strong>Market</strong> Outlook and Investment Opportunities<br />

Appendix<br />

a) List of Tables


) List of Figures<br />

For more related reports from Healthcare IT segment:<br />

A. Genomics <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/global-genomicsmarket-2610/<br />

B. Medical Tourism <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/globalmedical-tourism-market-1855/<br />

C. Transcatheter Aortic Valve Replacement (TAVR) <strong>Market</strong>:<br />

http://www.marketdataforecast.com/market-reports/transcatheter-aortic-valvereplacement-market-357/<br />

D. Empty Capsules <strong>Market</strong>: http://www.marketdataforecast.com/marketreports/global-empty-capsules-market-439/<br />

SCOPE OF THE REPORT<br />

<br />

<br />

<br />

<br />

<br />

Global, regional and country-level analysis and forecasts of the study market;<br />

providing Insights on the major countries/regions in which this industry is blooming<br />

and to also identify the regions that are still untapped<br />

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />

market and their impact on shifting market dynamics<br />

Study of the effect of exogenous and endogenous factors that affect the global<br />

market; which includes broadly demographic, economics, and political, among other<br />

macro-environmental factors presented in an extensive PESTLE Analysis<br />

Study the micro environment factors that determine the overall profitability of an<br />

Industry, using Porter’s five forces analysis for analyzing the level of competition<br />

and business strategy development<br />

A comprehensive list of key market players along with their product portfolio,<br />

current strategic interests, key financial information, legal issues, SWOT analysis and<br />

analyst overview to study and sustain the market environment


An executive summary, abridging the entire report in such a way that decisionmaking<br />

personnel can rapidly become acquainted with background information,<br />

concise analysis and main conclusions<br />

ABOUT US<br />

<strong>Market</strong> Data Forecast is a firm working in the areas of market<br />

research and business intelligence. We have rich experience in<br />

research across various business domains and we cater to the needs<br />

of both individual and corporate clients. Our research services assist<br />

clients in key business areas like business process improvement, key<br />

decision making and developing appropriate corporate strategy. We<br />

are truly committed to our clients and other stakeholders for<br />

providing customized research services of the highest quality.<br />

CONTACT INFORMATION<br />

We always look forward to working with new clients, pushing our<br />

boundaries and extending our reach beyond global horizons. Get in<br />

touch with us for further queries.<br />

Website: www.marketdataforecast.com<br />

E-Mail: contact@marketdataforecast.com<br />

Phone: +1 888-702-9626 (U.S Toll free),<br />

+91 7680952236 (Indian Office).<br />

FOR MORE INFORMATION

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!